Completed
A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
NCT00224497
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- GSK Investigational Site Hall in Tirol, Austria
- GSK Investigational Site Innsbruck, Austria
- GSK Investigational Site Retz, Austria
- GSK Investigational Site Vienna, Austria